The research report provides a big picture on Balantidiasis Market Share on a global basis, offering a forecast and statistic in terms of revenue during the forecast period
The global balantidiasis market is expected to grow at a CAGR of 2.1% during the forecast period.
Balantidiasis, also known as Balantidium coli infection, is a disease caused by intestinal protozoan parasite Balantidium coli. Being transmitted through the fecal-oral route, a person acquires the disease by ingesting infective cysts from food and water contaminated by feces. The global market is growing steadily and is expected to continue its growth during the forecast period.
The disease mainly affects large intestine. Diarrhea, weight loss, dysentery, abdominal pain, nausea, and vomiting are common symptoms for balantidiasis. The diseases is found to be prevalent in the rural areas of the developed and developing countries due to the contamination of water by the fecal matter of pigs or humans. The best remedy for the prevention of the disease are maintaining proper conditions for clean and safe drinking water. Antibiotics are most widely used for the treatment of balantidiasis.
Rising prevalence of gastrointestinal disorders, increasing number of patients and availability of treatment of balantidiasis drives the growth of the market. Additionally, the lack of hygiene and sanitation in the rural areas of developing countries is one of the many factors which affect the spread of this disease. Furthermore, rising awareness about the diseases transmitted through fecal-oral route influences the market growth. Competition among existing market players restrict the entry of new players.
Top Key Players of this Market:
Some of the key players in this market are Pfizer (U.S.), Abbott (U.S.), GlaxoSmithKline plc. (U.K), BD (U.S.), Sandoz International GmbH (Germany), Amneal Pharmaceuticals LLC. (U.S.), Akorn, Inc. (U.S.), and PharmaDerm, a division of Fougera Pharmaceuticals Inc. (U.S.).
Regional Analysis of the Global Balantidiasis Market:
The balantidiasis market is found to be steady in Americas. The disease is less prevalent in North America due to high quality standards, negligible number of cases, and hygienic environment. Furthermore, emphasis on healthy life style and prevention of communicable diseases also influence the growth of the market. The prevalence of the disease is found to the higher rural South America than North American countries.
In Europe, the prevalence of balantidiasis is found to be low. Rising importance of hygienic food products and water, rigorous quality checks, rising expenditure on healthcare, and availability of funds boost the growth of the market.
In Asia Pacific, the prevalence of balantidiasis is found increasing steadily as a result of increasing prevalence of colitis, chronic diarrhea, and, deep intestinal ulcerations and poor hygienic conditions in developing countries. The infection is found to be sub clinical leading to the development of diarrhea leading to the perforation of colon. Furthermore, poor healthcare system in developing countries boost the market growth. Furthermore, the burden of gastrointestinal diseases is attributed to an increase in age, high prevalence of H pylori and lifestyle changes with risk factors such as smoking and obesity. According to the data from GLOBOCAN, in 2012, the age-standardized rate (ASR) of incidence for Asia Pacific was 15.8 and mortality was 11.7 per 100,000. According to World Health Organization (WHO), the geriatric population in China in the year 2013 was 22.6 million which is expected to show a massive growth to 90.4 million in 2050.The Middle East & African region has high prevalence of balantidiasis. The infection is mainly acquired due to ingestion of food and water contaminated by cysts. Furthermore, gastrointestinal diseases are a major cause of disability in the Middle East & Africa. In Africa, the market for balantidiasis is driven by rising demand for primary care services and improving healthcare system.
Read More https://www.marketresearchfuture.com/reports/balantidiasis-market-4725
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
Marasmus is a type of protein malnutrition.
It happens when the person intake of protein and calories is too low.
It leads to weight loss of the body and stopping of vital functions.
A child with marasmus may not grow as children usually do.
Both adults and children can develop marasmus, but it most commonly seen in young children’s in developing countries.
The main symptoms of marasmus are low muscle mass, subcutaneous fat, intellectual disability, stunted growth, chronic diarrhea and respiratory infections.Global marasmus treatment market is growing at a steady CAGR in the forecast period of 2020-2027.
Bone Metastasis Market Analysis By Type (Osteolytic Bone Metastasis, Osteoblastic Bone metastasis), Treatment, Diagnosis, Key Players, Dynamics, Trends and Segmentation, Forecast To 2023
Bone metastasis is occurring when cancerous cells spread from the infected organ to a bone.
Common symptoms of bone metastasis are urinary bowel incontinence, incontinence and hypercalcemia.
The global Bone Metastasis Market size to witness a CAGR of 8.4% approximately over the forecast period of 2017 to 2023.
Additionally, factors such as, growing research and development in healthcare sector, rising healthcare expenditures by governments worldwide and geriatric population in the market are responsible for the bone metastasis market growth over the forecast period.
Request Free Sample Report at: https://www.marketresearchfuture.com/sample_request/5776
11 December 2018, the global Visceral Pain Market is expected to reach USD 14.22 billion by 2024, driven by the increasing geriatric population globally.
Increasing prevalence of visceral pain and rising awareness regarding the same is projected to drive market growth over the forecast period.
In 2016, North America held the majority of share in global visceral pain market owing to the increasing healthcare expenditure.
Additionally, the high prevalence of Crohn’s and irritable bowel is expected to propel the growth of the market over the projected period.Asia Pacific is expected to be the fastest growing region with the CAGR of 6.2%.
Furthermore, rising healthcare expenditure and an increasing use of opioids for the chronic pain are the key factors attributing to its share.Browse Details of Report @ https://www.hexaresearch.com/research-report/visceral-pain-marketIn 2016, Crohn’s disease was the largest indication segment for the visceral pain market contributing to 41.4% of the market share.
Furthermore, increasing awareness about Crohn’s disease is fueling the demand for treatment therapies.Key market players include Pfizer, Johnson & Johnson, Abbvie, Takeda, Allergan, and AstraZeneca.
Health Insurance Market Analysis/Health Insurance Market TrendsThe global health insurance market size is predicted to touch USD 141.3 billion at a 4.1% CAGR between 2019- 2025, reveals the new Market Research Future (MRFR) report.
These factors, as per the new MRFR report, include advancement in research and development activities in the medical sector, increase in per capita disposable income, growing government initiatives, increasing health expenditure, adoption of social media to create health awareness, and rising geriatric population.
Based on demographics, the health insurance market is segmented into senior citizens, adults, and minors.
Based on type, the global health insurance market is segmented into preferred provider organizations (PPO), point-of-service (POS) plans, exclusive provider organizations (EPOs), and health maintenance organizations (HMOs).
Net profit margins in the region are also high, led by Singapore and Hong Kong.
Health Insurance Market Key PlayersEminent players profiled in the health insurance market report include HealthCare International (UK), MultiNational Underwriters (US), CIGNA (US), Expacare (UK), International SOS (Asia), Aetna (US), IHI-Bupa (UK), Allianz SE (Germany), MediCare International (UK), William Russell (UK),, Blue Cross (US), and Integra Global Health Limited (UK).
Health Insurance Market AnalysisThe global health insurance market size is predicted to touch USD 141.3 billion at a 4.1% CAGR between 2019- 2025, reveals the new Market Research Future (MRFR) report.
Health insurance, simply put, is an insurance cover that pays for surgical, medical, and dental expenses incurred by the insured.
These factors, as per the new MRFR report, include advancement in research and development activities in the medical sector, increase in per capita disposable income, growing government initiatives, increasing health expenditure, adoption of social media to create health awareness, and rising geriatric population.
On the contrary, strict rules and regulations, and poor track record of claim settlement are factors that are likely to impede the global health insurance market growth over the forecast period.
Based on demographics, the health insurance market is segmented into senior citizens, adults, and minors.
Based on type, the global health insurance market is segmented into preferred provider organizations (PPO), point-of-service (POS) plans, exclusive provider organizations (EPOs), and health maintenance organizations (HMOs).
Wherever there's an available supply of electricity, higher speed Internet access can be found.
Get more information about unlimited wireless internetWireless internet allows wireless connectivity from a computer to the World Wide Web via radio signals instead of wires on the consumer s home computer, notebook computer, smartphone, or other wireless device.
The signals used for wireless net connections are known as WAN (Internet Traffic Exchange), EoE (Estate of Equipment Exchange), or Wi-Fi (World Wide Wi-Fi).
To gain access to the net an individual must connect to a WAN router or gateway using a computer or one having an open wireless network card (a), a USB cord, and a username and password set by the user.
There are different types of wireless routers, some of which offer more security features like WPA safety and also have faster upload speeds.
Some offer two-factor authentication, another safety feature that can help prevent unauthorized access to computers.Many homes, businesses, and libraries currently have wireless internet available.
